Clinical Trial Update: Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating ebastine for diarrhea-predominant irritable bowel syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• Ebastine (ebastine)

Snippet

Sponsor: Md. Hazrat Ali | Conditions: Irritable Bowel Syndrome - Diarrhoea | Phase 2, Phase 3 | Status: RECRUITING